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The ubiquitin ligase Smurf1 can target a handful of signaling proteins for ubiquitin-mediated proteasomal destruction or functional
modification, including TGF-β receptors, Smads, transcription factors, RhoA and MEKK2. Smurf1 was initially implicated in BMP pathway
regulation in embryonic development, but its potential role in vertebrate embryogenesis has yet to be clarified. Here we demonstrate that inhibition
of Smurf1 in Xenopus laevis embryos with an antisense morpholino oligonucleotide or a dominant-negative protein disrupts early development,
with the nervous system being the principal target. Smurf1 is enriched on the dorsal side of gastrula stage embryos, and blocking Smurf1 disturbs
neural folding and neural, but not mesoderm differentiation, enhances BMP/Smad1 signaling, and elevates phospho-Smad1 levels in the dorsal
ectoderm. We conclude that in Xenopus embryos, the BMP pathway is a major physiological target of Smurf1, and we propose that in normal
development Smurf1 cooperates with secreted BMP antagonists to limit BMP signaling in dorsal ectoderm. Our data also reveal a novel role for
Smurf1 and Smad1 in neural plate morphogenesis.
© 2006 Published by Elsevier Inc.Keywords: Smurf1; Smad1; BMP; Ubiquitin ligase; Neural tube; Neural folding; Neural patterning; Signal transduction; Embryo; Xenopus laevisIntroduction
Smurf1 is a member of the HECT class of E3 ubiquitin
ligases, and it is evolutionarily conserved from Drosophila
through man (Zhu et al., 1999; Podos et al., 2001; Ebisawa et
al., 2001). Smurf1 and the related Smurf2 are characterized
by an N-terminal phospholipid binding or C2 domain, two or
three WW domains that bind PPXY consensus motifs in
partner proteins and substrates, and a C-terminal catalytic
HECT domain (Zhu et al., 1999; Pickart, 2001a). Ubiquitin
ligases catalyze transfer of ubiquitin from an E2, ubiquitin-
conjugating enzyme, onto target proteins that results in their
proteasomal or lysosomal degradation, or regulates their
subcellular localization, trafficking or protein–protein interac-
tions (Pickart, 2001a, b). We originally isolated Smurf1 as a⁎ Corresponding author. Fax: +1 631 632 8575.
E-mail address: gerald.h.thomsen@sunsyb.edu (G.H. Thomsen).
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doi:10.1016/j.ydbio.2006.08.009Smad1-interacting factor by a yeast two-hybrid screen (Zhu et al.,
1999).
Smad1 is a signal transducer in the canonical bone
morphogenetic protein (BMP) signal transduction pathway
that plays an important role in several events during
vertebrate embryonic development: (1) the patterning of the
ventro-lateral mesoderm; (2) the decision between epidermal
and neural cell fate, in which high activity of Smad1/5
specifies epidermis, intermediate activity specifies the “neural
border” fates (e.g. neural crest and cement gland), and in the
absence of BMP/Smad1 signaling, neural induction takes
place; (3) dorsoventral patterning of the neural tube, wherein
BMPs are responsible for differentiation of dorsal neuronal
subtypes (Dale and Wardle, 1999; Harland, 2000; Hill, 2001;
De Robertis and Kuroda, 2004; Chizhikov and Millen, 2005;
Wilson and Maden, 2005).
BMP signaling commences when homo- or heterodimers
bind a complex of type I and type II Ser/Thr kinase
receptors, Smads 1, 5 or 8 (Smad1/5/8) get phosphorylated
and activated, bind to the co-partner Smad4 and translocate
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transcription (Lutz and Knaus, 2002). The BMP/Smad1
pathway can be negatively regulated at several levels: by
extracellular BMP antagonists such as Noggin and Chordin,
pseudoreceptors (e.g. BAMBI), inhibitory Smads, MAP
kinases and Smad ubiquitylation regulatory factors or Smurfs
(reviewed by von Bubnoff and Cho, 2001; Lutz and Knaus,
2002; De Robertis and Kuroda, 2004).
We have shown that Smurf1 can ubiquitylate and down-
regulate Smad1/5 (Zhu et al., 1999; see below), but it also has
a number of other potential targets that depend on the cell.
For example, in C2C12 and 2T3 cells, Smurf1 can suppress
BMP/Smad5 signaling and osteoblast differentiation by
ubiquitylating Smad5 (Ying et al., 2003) or the osteoblast-
specific transcription factor Cbfα1/Runx2 (Zhao et al., 2003,
2004; Kaneki et al., 2006). In overexpression assays, Smurf1
can target the TGF-β type I receptor (TBRI), BMP type I
receptor (ALK6), Smad4 and inhibitory Smad7 for proteaso-
mal degradation (Moren et al., 2005; Ebisawa et al., 2001;
Suzuki et al., 2002; Murakami et al., 2003; Zhu et al., 1999
supplementary data). Furthermore, endogenous Smurf1-
dependent ubiquitylation can trigger degradation of the
small GTPase RhoA to affect cell protrusive activity and
polarity (Wang et al., 2003), neurite outgrowth (Bryan et al.,
2005) or epithelial cell tight junction dissolution in TGF-β-
induced epithelial–mesenchymal transition (Ozdamar et al.,
2005).
By misexpressing Smurf1 in Xenopus embryos, we
previously found that Smurf1 can cause incomplete secondary
axis formation by dorsalizing ventral marginal zone tissue,
and Smurf1 can neuralize embryonic ectodermal explants
(Zhu et al., 1999). However, a loss-of-function analysis of
Smurf1 in Xenopus embryos is needed to reveal which, if
any, of these phenomena are relevant in vivo. Smurf1 loss-of-
function studies have been accomplished in Drosophila and
mouse, with somewhat different results. Drosophila maternal-
zygotic dSmurf mutants display enhanced and prolonged
DPP/BMP signaling (Podos et al., 2001) as a consequence of
stabilized phospho-MAD, the activated Drosophila homolog
of vertebrate Smad1/5 (Liang et al., 2003). In contrast,
Smurf1 knockout (KO) mice do not have developmental
defects, but are characterized by an age-dependent increase in
bone mass through enhanced osteoblast activity (Yamashita et
al., 2005). Although osteoblasts from these mice are
sensitized to BMP signaling, Smurf1 does not directly affect
the levels of Smad1 or BMP receptors. Instead, MEKK2 is
stabilized and activates JNK. The mouse results in particular
raise the question of whether or not Smurf1 targets the BMP/
Smad1 pathway under physiological situations in developing
vertebrate embryos.
Here we report that blocking endogenous Smurf1 in Xe-
nopus embryos with an antisense morpholino oligonucleotide
(MO), or a dominant-negative mutant protein, disrupts neural
folding and patterning, greatly affecting head development.
We show that up-regulation of the BMP/Smad1 signaling
pathway is the underlying cause of the knockdown
phenotypes.Materials and methods
Embryo manipulations, in situ hybridization, morpholino oligos and
synthetic mRNAs
Xenopus laevis embryos were obtained by standard in vitro fertilization,
de-jellied in 2% cysteine pH8.0, microinjected and incubated for several hours
in 3% ficoll+0.5×MMR+10 μg/ml gentamycin and grown in 0.1×MMR+
10 μg/ml gentamycin thereafter. 30–40 ng Smurf1 MO or 0.10–0.20 ng
Smurf1CA mRNA was injected into the dorsal-animal region of the 4–8 cell
stage embryos, unless indicated otherwise. All stages are according to
Nieuwkoop and Faber (1967). Animal caps were excised at stage 8;
prospective neural ectoderm (NE) and ventral ectoderm (VE) were excised
at stage 10.25 as 60°-wide sectors on either the dorsal or the ventral side, from
the animal pole to the bottom of the pigmented zone. The explants were cut
and cultured in 0.5×MMR+10 μg/ml gentamycin until the sibling embryos
reached the appropriate stage. In situ hybridization was as previously described
(Harland, 1991) using BM purple as a chromogenic substrate (Roche).
Template plasmids for making probes were pCS2-Smurf1, pGEM-Pax6, pBS-
SK-Otx2, pBS-KS+En2, pGEM-Krox20, pBS-NCAM, pCS2-reverse-Msx1,
pBS-SK-XNkx2.2, pBS-Sox2 and pBS-Xep. Morpholino oligo sequences are:
standard control MO-5′cctcttacctcagttacaatttata3′, Smurf1 MO-5′attcga-
catccctccaaacgccg3′ (Gene Tools, LLC, Philomath, OR). Full-length X. laevis
Smad6 and zebrafish Danio rerio zSmurf1 were obtained as EST clones (I.
M.A.G.E. consortium, clone ID numbers 6317366 and 5915182, respectively)
and verified by sequencing. zSmurf1 was subcloned into pCS2 using EcoRI and
XbaI sites. Capped synthetic mRNAs were in vitro transcribed using
mMESSAGE mMACHINE kits (Ambion) from the following linearized
plasmids: pCS2-Smurf1, pCS2-Smurf1CA, pCS2-zSmurf1, pCS2-Smad1,
pSPYS-Chordin, pCS2-BMP4, pCMV-SPORT6-Smad6.
In vitro translation, Western blot analysis, antibodies and phalloidin
staining
Smurf1 proteinwas in vitro translated usingTnTT7/SP6Coupled Reticulocyte
Lysate system (Promega) in the presence of control or Smurf1 MO and [35S]
methionine, according to the manufacturer's protocol. Half of each reaction was
resolved by 8% SDS-PAGE, visualized by autoradiography and quantified using
NIH Image software. ForWestern blot analysis, three total embryos (Fig. 2C) or 15
explants (Fig. 11) were lysed and the proteins were resolved by 8% SDS-PAGE. A
Smurf1 monoclonal antibody (Wang et al., 2003) was used at 1:4 dilution; β-
tubulin antibody was used at 1:20,000 dilution (Accurate Chemical and Scientific
Corporation); P-Smad1/5 antibody was used at 1:200 dilution (Cell Signaling
Technology, Inc.); AF680 goat anti-rabbit and AF800 goat anti-mouse secondary
antibodies were used at 1:2000 dilution (Molecular Probes). Resolved proteins
were visualized and quantified using the Odyssey Infrared Imager (LI-COR, Inc.).
F-actin staining was done using 1:100 AF488-phalloidin (Molecular Probes) on
stage 18 embryos fixed 30 min in MEMPFA.
Quantitative RT-PCR
Total RNAwas extracted from 10–15 animal caps or one wt embryo in the
presence of 0.25 μg/ml proteinase K, phenol/chloroform extracted and ethanol
precipitated, treated with DNaseI and phenol/chloroform extracted/ethanol
precipitated again. 1 μg of total RNAwas used to synthesize cDNA and 1/30 of
the resulting cDNA was used in each RT-PCR reaction. The primers to Xagr2
(Novoselov et al., 2003), 5′gaaccagctgatattgatcatttg3′ (upstream) and 5′
aatggtctccttcatacaccac3′ (downstream), were used at the following conditions:
95°C/10 s, 55°C/5 s, 72°C/12 s, acquisition temperature 79°C. The primers to
XAG1, 5′ctgactgtccgatcagac3′ (upstream) and 5′gagttgcttctctggcat3′ (down-
stream), were used at the following conditions: 95°C/10 s, 55°C/6 s, 72°C/12 s,
acquisition temperature 85°C. Primers and cycling conditions for ODC, N-
CAM, Wnt8, Vent1, GATA6 and αT4-globin were previously described (Kofron
et al., 1999; Xanthos et al., 2001; Tao et al., 2005). Quantitative RT-PCR using
LightCycler System (Roche Applied Science) was previously described (Kofron
et al., 1999). We used 1:1, 1:10, 1:100 and 1:1000 dilutions of the cDNA from a
wt embryo to generate standard curves. Expression levels of all genes were
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to the corresponding endogenous gene expression level in a whole embryo, and
plotted as percentage thereof.Results
Smurf1 knockdown disrupts anterior neural development
To analyze the in vivo function of Smurf1 in Xenopus
embryos by a loss-of-function approach, we first re-examined
the distribution of Smurf1 transcripts in more detail than
previously reported (Zhu et al., 1999). Embryos were bisected at
gastrula and neurula stages and subjected to in situ hybridiza-
tion. This revealed an enrichment of Smurf1 at the onset of
gastrulation in dorsal compared to ventral animal pole and
marginal zone (Figs. 1A, A′). In early (stage 14) and late (stage
20) neurula embryos, Smurf1 transcripts are present in the
neural plate, somitogenic mesoderm, somites, prechordal plate
and notochord (Figs. 1B–C′). These patterns suggested to us
that Smurf1 contributes to neural and/or dorsal mesodermal
development. To address the endogenous function of Smurf1,
we used gene knockdown and dominant negative approaches.
To knockdown Smurf1, we designed a Smurf1 morpholino
oligonucleotide (MO) that would target Smurf1, but not the two
Smurf2 alleles found in X. laevis (Fig. 2A). Notably, despite the
pseudotetraploid nature of X. laevis, we were unable to detect in
any X. laevis EST database Smurf1 transcripts that differ from
the one we originally reported (Zhu et al., 1999). The Smurf1
antisense MO, but not a control MO, efficiently blocked Smurf1
translation in coupled transcription/translation reticulocyte
lysate reactions (Fig. 2B). In addition, this MO inhibited
Smurf1 production in Smurf1 mRNA-injected embryos up to
80% (Fig. 2C) and blocked secondary axis induction by ectopic
wild-type (wt) Smurf1 (Figs. 2D–F). As an alternativeFig. 1. Smurf1 transcripts are enriched in the dorsal tissues. (A, A′) Lateral view and
asterisks mark the dorsal blastopore lip). (B, B′) Early neurula, stage 14. (C, C′) Late
sections, (C′) transversal section. S—somites, sm—somitogenic mesoderm, black
plate.approach, we employed a catalytically inactive Smurf1
Cys699Ala mutant (Smurf1CA), previously reported to act as
a dominant-negative in mammalian C2C12 cells (Zhao et al.,
2003). Consistent with its reported dominant-negative activity,
Smurf1CA also blocked wt Smurf1-induced ectopic axes in
Xenopus embryos (Fig. 2G).
To determine regional requirements for Smurf1 in normal
development, we injected the Smurf1 MO (details in Methods),
or 0.1–0.2 ng Smurf1CA mRNA into blastomeres with well-
known tissue fates. Injections targeting ventral blastomeres at
the 4–8 cell stage, which are fated to form epidermis and
ventro-posterior mesendodermal tissues (Moody, 1987), did not
affect development (data not shown). However, animal–dorsal
injections at the 4–8 cell stage, that mainly target prospective
neural ectoderm (Moody, 1987), caused defective neural
folding, microcephaly, and micropthalmy (Figs. 3A–D).
Consistent with these early phenotypes, Smurf1 KD embryos
reared to feeding tadpole stages 45–50 showed reduced eyes
and pigmentation, and an overall smaller size (Fig. 4G). Defects
in neural plate folding caused by either Smurf1 MO or
Smurf1CA treatment were accompanied by loss of f-actin
bundles at neural fold hinge points, revealed by phalloidin
staining (Figs. 3F–I, arrows). Of note, injection of these
blocking reagents into prospective dorsal mesoderm (by
targeting dorsal–vegetal blastomeres at the 8-cell stage;
Moody, 1987) did not cause any abnormalities. The onset and
progression of gastrulation, as well as axis elongation occurred
normally (data not shown). These first tests thus indicated a role
for Smurf1 in neural, but not mesodermal development (a
conclusion backed up by molecular analysis, below).
Focusing on the neural defects, we performed rescue
experiments as an important control for specificity of the
knockdown reagents. Co-injection of wt X. laevis Smurf1or
zebrafish Smurf1 (zSmurf1) mRNA rescued the neural foldingsagittal section of early gastrula, stage10 (animal pole up, dorsal side at the right,
neurula, stage 20. In panels B, B′ and C, anterior is at the right, (B′, C) sagittal
arrowheads—neural folds, black arrow—notochord, white arrow—prechordal
Fig. 2. Characterization of Smurf1 MO and Smurf1CA effectiveness. (A) Alignment of Smurf1 MO sequence with Xenopus laevis (X.l.) Smurf1, zebrafish Danio
rerio Smurf1 (zSmurf1) and two versions of X. laevis Smurf2. The translation start site is in bold. (B, C) The amount of Smurf1 protein produced by in vitro translation
(B) or in the embryos injected with Smurf1mRNA (C) is reduced in the presence of Smurf1 MO, but not control MO. (D–G) Smurf1 MO (F) and Smurf1CA (G) block
secondary axis induction by the wild-type Smurf1 (E).
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phenotypes of Smurf1CA and Smurf1 MO embryos, respec-
tively (Table 1 and Fig. 4). zSmurf1 is structurally and
functionally homologous to X. laevis Smurf1, as determined
by conservation of their primary protein sequence and ability to
induce secondary axes when ectopically expressed in Xenopus
embryos (Supplementary Fig. 1). Note that Smurf1 MO and
zSmurf1 mRNA sequences have 9 base mismatches (Fig. 2A)
and therefore should not interact with each other). Our resultsFig. 3. Knockdown of endogenous Smurf1 results in neural defects. (A–D) Smurf1 M
cause neural tube closure defects at neurula stages (top row) and microcephaly and m
ng Smad1 mRNA overexpression (E). (F–I) F-actin accumulation at the neural fold h
have normal loop-shaped pattern. In Smurf1MO (G) or Smurf1CA embryos (I), f-act
Scale bar=0.1 mm.indicate that endogenous Smurf1 is required for neural, but not
mesodermal development, particularly in closure of the anterior
neural tube, and formation of the eyes and head.
Suppression of neural and up-regulation of epidermal genes in
Smurf1 knockdown embryos
To understand the phenotypes in more detail, we asked next
whether Smurf1 knockdown defects were accompanied byO (B) and Smurf1CA (D), but not control MO (A) or control β-gal mRNA (C)
icrophtalmy at tailbud stages (bottom row). This phenotype is mimicked by 1–6
inge points at stage 18, revealed by phalloidin staining. Control embryos (F, H)
in staining is weak and the distance between the lateral hinge points is increased.
Fig. 4. Rescue of Smurf1 MO and Smurf1CA embryos by wild-type Smurf1. (A–C, G) Neural folding defect (B) and overall phenotype of tadpoles caused by
Smurf1MO is rescued by 0.1 ng of zSmurf1 mRNA (C, G). (D–F) Smurf1CA embryos are similarly rescued by X. laevis Smurf1.
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on neurula stage embryos showed that a variety of regional
neural markers were suppressed and/or mispatterned in Smurf1
MO and Smurf1CA embryos, including the forebrain marker
Otx2, prospective eye marker Pax6, mid-hindbrain boundary
marker En2 and rhombomeres 3 and 5 marker Krox20 (Figs.
5A–L). Similarly, the floorplate staining of a Shh target Nkx2.2
was reduced (our probe did not penetrate deep enough to stain
the notochord, data not shown) (Figs. 5S–U). Importantly, the
disruption of neural marker staining patterns was not associated
with tissue death or lysis (Supplementary Fig. 2). In contrast to
regional markers, the general neural markers N-CAM and Sox2
were not significantly changed, although N-CAM staining was
weaker in some, but not all experiments (Figs. 5M–R, 6H–L,
and data not shown).
In contrast to marker reduction above, expression domains
of both the neural border marker Msx1 (Figs. 6A–D, arrow-Table 1
Rescue of Smurf1 knockdown embryos by wt Smurf1
N a %
NTDs b
N a % eye
defects
Uninjected 46 0 28 0
Control MO, 35 ng 34 0.9 Not scored
Smurf1 MO, 35 ng 44 77.3 24 58.3
Smurf1 MO, 35 ng+ zSmurf1 mRNA,
0.1 ng
38 13.2 26 34.6
Uninjected 33 9.1 54 11.1
Smurf1CA mRNA, 0.1 ng 31 64.5 58 53.6
Smurf1CA mRNA, 0.1 ng+Smurf1 mRNA,
0.2 ng
32 9.4 56 28.6
a N—number of embryos or eyes scored.
b NTD (neural tube defects)-defective neural folding scored at stages 18–20.heads) and the epidermal marker Xep (Figs. 6E,F,H–L, arrows)
were expanded in Smurf1 KD embryos. Notably, Xep also has
a neural domain of expression (Vasiliev et al., 1997) that was
lost in Smurf1 KD embryos (Figs. 6E–G, asterisk), but the
normal pattern of Xep expression was restored by co-injection
of 0.2 ng of wt Smurf1 mRNA (Figs. 6G, M). Altogether, these
data indicate that in Smurf1 KD embryos a moderate
conversion of neural to non-neural cell fate takes place.
Moreover, this does not seem to be mediated by defects in
mesoderm patterning, as none of the mesoderm markers
analyzed was affected in Smurf1CA and Smurf1 MO embryos
(Fig. 7 and data not shown).
Smad1 overexpression mimics Smurf1 knockdown
We hypothesized that the embryonic phenotype generated by
Smurf1 knockdown was caused by stabilization of one or more
of Smurf1 targets that, under normal conditions, would be
degraded due to Smurf1-mediated ubiquitylation. If so, then
overexpression of a potential target(s) would be expected to
mimic Smurf1 knockdown phenotype. Several Smurf1 targets
have been identified (see Introduction), of which the BMP/
Smad1 pathway is arguably the most critical known effector of
neuroectodermal and ectodermal induction and patterning
(Wilson et al., 1997; Harland, 2000; De Robertis and Kuroda,
2004). We tested the ability of several potential targets to mimic
Smurf1 KD. Notably, Smad1 (Fig. 3E), but not RhoA
(Supplementary Fig. 3) caused nearly identical defects as
Smurf1 KD.
We then tested to what extent would the neural-to-epidermal
conversion take place in Smad1 overexpressing embryos.
Although 6 ng Smad1 mRNA potently induced Xep and Msx1
Fig. 5. Smurf1 knockdown disrupts neural gene expression. Anterior neural marker Otx2 (A–D), prospective eye marker Pax6 (E–H), rhombomere 3 and 5 marker
Krox20 and the marker of mid-hindbrain boundary En2 (I–L) at late neurula stage 18. Pan-neural marker N-CAM at stage 18 (M–P) and stage 14 (Q, R). (S–U) Shh
target gene in the neural plate, Nkx2.2, at stage 17. All are anterior views.
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mRNA were very similar to Smurf1 knockdown. Specifically,
N-CAM was only slightly suppressed (Fig. 8B), whereas Xep
(Fig. 8D, arrow) and Msx1 (Fig. 8G, arrowheads) were up-
regulated at the periphery of the neural plate, and the neural
domain of Xep disappeared (Figs. 8C, D asterisk). In spite of
just a moderate conversion of the neural plate cells into
epidermis, neural folding movements were strongly inhibited,
as revealed by a wider N-CAM staining pattern (Fig. 8B) and
wider unstained area in Xep and Msx1-stained embryos
(Figs. 8D, G), in agreement with the overall phenotype (Fig.
3E). These data demonstrate a significant degree of
correlation between the effects of Smurf1 knockdown and
moderate Smad1 overexpression, which points to the BMP/
Smad1 pathway as a primary physiological target of Smurf1
in Xenopus embryos.
Smad6 rescues Smurf1 knockdown embryos
To test whether BMP/Smad1 pathway is activated in
neuroectoderm of Smurf1 KD embryos, we attempted to rescue
the Smurf1 KD phenotype by Smad6, an inhibitory Smad
specific for the BMP pathway that acts by disrupting Smad1/5–
Smad4 complex formation (Hata et al., 1998). We found that
indeed, co-injection of 1 ng Smad6 mRNA rescued the neuralfolding defects in Smurf1 MO embryos (Figs. 9A, C) and
Smurf1CA embryos (Figs. 9B, D), and Sox2 and Xep ex-
pression patterns in Smurf1CA embryos (Fig. 6N). These
results demonstrate that the defects caused by loss of Smurf1
function result from enhanced BMP/Smad1 signaling in the
neural plate.
Endogenous Smurf1 is required for neural induction in animal
pole ectoderm and ventral patterning
Since Smurf1 knockdown affects both neural folding and
patterning in whole embryos, we attempted to determine
whether blocking Smurf1 in animal caps affects neural
differentiation independent of apparent cell movements, using
neural differentiation assays with isolated animal cap ectoderm.
The epidermal and neural fates of primary ectoderm are
specified by differential activation of the BMP/Smad1 pathway:
elevated Smad1 signaling triggers epidermal differentiation,
while absent or sub-threshold Smad1 signaling allows neural
differentiation (Wilson et al., 1997; Harland, 2000; De Robertis
and Kuroda, 2004). We activated neural differentiation in
animal caps by injecting 0.5 ng or 1 ng mRNA of the secreted
BMP antagonist, Chordin. This potently induced N-CAM in the
presence of control MO, but co-injection of the Smurf1 MO
greatly reduced both the number of N-CAM positive caps and
Fig. 6. BMP-responsive genes are up-regulated by blocking Smurf1. (A–D) The zone of Msx1, a marker of the neural plate border, is wider in Smurf1 MO and
Smurf1CA embryos (B, D, arrowheads), than in control embryos (A, C). (E–G) Expression pattern of the epidermal marker, Xep, encroaches into the placodal zone (F,
arrow), but loses its neural domain (asterisk) in Smurf1CA embryos. Its normal pattern is rescued by wt Smurf1 (G). Pink color demarcates lineage tracing by β-gal.
(H–L) Double staining of control, Smurf1 MO and Smurf1CA embryos with Xep (purple, arrows) and Sox2 (cyan) and rescue of the Xep pattern by wt Smurf1 (M)
and Smad6 (N). All are anterior views.
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Smurf1CA suppressed induction of neural and cement gland
markers by Chordin in animal caps, as scored by quantitative
RT-PCR on N-CAM, XAG1 and Xagr2 genes (Fig. 10C). Thus,
defects in neural differentiation are unlikely due to effects of
Smurf1 KD on cell movements.Fig. 7. Mesodermal markers are not affected by blocking Smurf1. General mesoderma
and the marker of the Organizer and notochord Chd (E–H) are expressed normally i
animal pole up. Representative embryos are shown.Besides the ectoderm, we were also able to reveal
endogenous Smurf1 activity in ventral marginal zone
(VMZ) tissues, which also express Smurf1 but at a lower
level than in the DMZ (Fig. 1). We found that Smurf1CA was
able to inhibit the ability of Chordin to induce secondary
axial structures when the two were co-injected in the VMZl marker XBra (A, B), the marker of the prospective head mesoderm Frzb (C, D)
n Smurf1CA embryos. (A–D) Vegetal view, dorsal side up. (E–H) Dorsal view,
Fig. 8. A low dose of Smad1 overexpression mimics Smurf1 knockdown. N-
CAM staining is slightly reduced (A, B), while Xep (D, arrow) and Msx1
(G, arrowheads) are up-regulated at the periphery of the neural plate in
embryos injected with 1 ng Smad1 mRNA. As a positive control, 6 ng
Smad1 mRNA strongly induces Xep (E, arrow) and Msx1 (H, arrowheads)
within the neural plate. Notice the wider neural plate in all Smad1-
overexpressing embryos (B, D, E, G, H). All are anterior views at stage 14
(A, B) or 17 (C–H).
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whole embryos by Chordin mRNA injection into the animal
pole at the two-cell stage (Fig. 10E). These findings reveal anFig. 9. A Smad1/5 antagonist, Smad6, rescues the Smurf1 knockdown phenotype. (A
Smurf1 MO (C) and Smurf1CA (D) rescue by Smad6 (n—number of embryos).underlying activity for endogenous Smurf1 in ventral/poster-
ior tissues that is exhibited when tissues are sensitized with a
BMP inhibitor (also refer to Discussion).
These data are consistent with elevation of endogenous
BMP/Smad1 signaling when Smurf1 is knocked down in
embryos. We propose that the function of Smurf1 in Xenopus
embryos is to impose a limit on the BMP/Smad1 signaling in
the ectoderm that is sufficient for epidermal differentiation of
non-neural ectoderm but low enough to permit neural induction
in the dorsal ectoderm.
Blocking Smurf1 enhances tissue responses to BMP signals
Animal caps provide a convenient way to analyze interac-
tions among genetic pathways. We have proposed that Smurf1
is an antagonist of Smad1 and that Smurf1 knockdown
sensitizes ectodermal cells to the BMP/Smad1 signals. To
further test the latter possibility, we examined the expression of
known BMP4 target genes in animal caps injected with a
limiting dose of BMP4 mRNA in the presence or absence of
Smurf1CA. BMP levels in isolated animal cap ectoderm are
already above the threshold required for the epidermal
specification, as evident by differentiation of animal cap
explants into epidermis (Grunz and Tacke, 1989). However,
by boosting BMP levels further, one can induce ventral
mesoderm in the animal caps (Jones et al., 1992; Hemmati-
Brivanlou and Thomsen, 1995). We therefore tested whether
blocking endogenous Smurf1 can cooperate with BMP4/Smad1
signaling to induce higher expression levels of BMP target
genes. We found that minor amounts of ventrolateral mesoderm
were induced by injection of limiting doses of BMP4 mRNA, B) Representative stage 18 (A) and stage 17 (B) embryos. (C, D) Summary of
Fig. 10. Blocking Smurf1 inhibits response to Chordin and enhances response to BMP. (A, B) Smurf1 MO, but not control MO, blocks neural induction by Chordin in
animal caps, as scored by in situ hybridization with N-CAM probe. (A) Combined data from two experiments (n—number of animal caps), (B) representative animal
caps from each treatment. (C) Similarly, Smurf1CA suppresses expression of N-CAM and two cement gland markers, XAG1 and Xagr2, in Chordin mRNA-injected
animal caps, as measured by quantitative RT-PCR at stage 25. (D) Smurf1CA also inhibits secondary axis induction by ChordinmRNA injected in the ventral marginal
zone (n—number of embryos). (E) Likewise, embryos injected with 1 ng ChordinmRNA in the animal pole are strongly dorsalized, which is reversed by co-injection
of Smurf1CA mRNA. (F) Quantitative RT-PCR on animal caps injected with BMP4 mRNA, with or without Smurf1CA. Expression of both early (Vent1 and Wnt8,
scored at stage 10.5) and late BMP4 target genes (GATA6 and αT4-globin, scored at stage 25) is enhanced by Smurf1CA. Panels C and F were repeated twice on
independent cDNA with similar results.
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mRNA was coinjected with either BMP4 or Smad1, we
observed significant elevation of early BMP target genes
marking ventro-lateral mesoderm (Vent1 and Wnt8, scored at
stage 10.5) and late markers of blood (GATA6 and αT4-globin
scored at stage 25; Fig. 10F and data not shown). These results
show that blocking Smurf1 in the ectoderm can counteract BMP
inhibition by antagonists such as Chordin, and also make
ectoderm more sensitive to BMP/Smad1 signals. These effectsFig. 11. Phospho-Smad1 levels are elevated in Smurf1CA embryonic neuroectoderm.
with indicated mRNAs and analyzed by Western blotting (A). (B) Quantitation of
experiments, error bars—standard deviation).are consistent with elevation of BMP/Smad1 signaling in
animal pole ectoderm when endogenous Smurf1 is inhibited.
We test this proposition more directly, next.
Phospho-Smad1 levels are elevated in proneural ectoderm of
Smurf1 knockdown embryos
To directly test whether blocking Smurf1 stimulates BMP/
Smad1 signaling in the ectoderm, we compared the levels of theDorsal (prospective neural) ectoderm was cut from stage 10.25 embryos injected
relative P-Smad1/5 levels summarized from four experiments (n—number of
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prospective neural ectoderm (NE) excised from wt and
Smurf1CA embryos (Fig. 11). We dissected the NE from 10
to 15 embryos at stage 10.25 and performed Western blot
analysis on the total proteins, staining simultaneously with
antibodies against P-Smad1/5, β-tubulin (loading control) and
Smurf1/Smurf1CA (expression control). Since there exists no
evidence of Smad5/8 expression in early X. laevis development,
protein staining likely represents just Smad1. We found that
stage 10.25 NE from Smurf1CA embryos contained P-Smad1
levels that were on average threefold higher than NE from wt
embryos, and similar P-Smad1 levels were produced by 1 ng
Smad1 mRNA injected on the dorsal side, substantiating our
earlier, phenotype-based finding that this dose of Smad1 mRNA
most closely imitates Smurf1 knockdown (see Figs. 3E, 8).
However, these levels of P-Smad1 did not reach levels as high
as seen in the ventral ectoderm (VE), which were fivefold over
control. This likely explains why the epidermal program is not
significantly initiated within the neural plate of Smurf1CA and
Smurf1 MO embryos, or embryos injected with 1 ng Smad1
mRNA (Figs. 6, 8D, G). A dorsal–ventral gradient of P-Smad1
has been observed in the animal hemisphere directly (Faure et
al., 2000; Schohl and Fagotto, 2002). Our knockdown of
Smurf1 almost eliminates this Smad1 signaling difference
between dorsal and ventral tissues. Importantly, the P-Smad1
present in Smurf1CA ectoderm is restored to normal low levels
by co-injection of wt Smurf1 (Fig. 11). These experiments
directly demonstrate that blocking Smurf1 function in Xenopus
embryos results in elevated phosphorylation of endogenous
Smad1, which is likely the basis of the phenotypic and
molecular defects described above.
Discussion
To summarize our findings, we have observed that blocking
endogenous Smurf1 suppresses neural folding and neural
patterning in whole embryos, inhibits neural induction and
enhances BMP sensitivity in animal caps, and increases
endogenous P-Smad1 levels in the prospective neural ectoderm.
All of these effects are mimicked by moderate Smad1
overexpression and can be rescued by inhibitory Smad6. We
conclude that the function of endogenous Smurf1 in Xenopus
embryos is to limit BMP/Smad1 signaling in the proneural
ectoderm. Therefore, Smurf1 acts as an intracellular BMP/
Smad1 signaling antagonist that likely synergizes with other
anti-BMP mechanisms operating on the dorsal side of the
embryo, such as Spemann organizer-derived BMP antagonists
and their cofactors (De Robertis and Kuroda, 2004; Wills et al.,
2006; Lebreton and Jones, 2006), a Smad4 ubiquitin ligase,
Ectodermin (Dupont et al., 2005) and β-catenin dependent
transcriptional repression of the BMP4 gene (Baker et al.,
1999).
The role of Smurf1 in X. laevis development
Previous work on Drosophila showed that dSmurf is
essential for embryonic dorso-ventral patterning and hindgutdevelopment, and that it acts by spatially and temporally
restricting DPP signaling (Podos et al., 2001). Information
about the potential developmental function of vertebrate
Smurf1, however, has been limited to overexpression studies
in Xenopus, where Smurf1 was shown to dorsalize mesoderm
and neuralize ectoderm (Zhu et al., 1999; Zhang et al., 2001),
and the phenotype of Smurf1 KO mouse (Yamashita et al.,
2005), which revealed a somewhat surprising lack of embryonic
defects considering that Smurf1 is expressed during gastrula,
neurula and later stages of mouse development (Yamashita et al.,
2005; G.H.T., unpublished data). However, Yamashita and
colleagues (2005) observed a two to threefold increase in
Smurf2 transcription in Smurf1 KO mice, which possibly
compensated for the loss of Smurf1 during mouse embryonic
development. Preliminary tests of Smurf1;Smurf2 double KO
mice (Yamashita et al., 2005) indicated embryonic lethality, so
the issue of whether or not Smurf1 has a function in vertebrate
embryogenesis has remained unresolved.
In our present study, we used Xenopus embryos to
investigate the developmental role of Smurf1. The stereotypical
fate map of the Xenopus embryo allowed us to target two
different loss-of-function reagents, a Smurf1 MO and a
dominant-negative mutant, into blastomeres that would give
rise to different tissues. We found that Smurf1 knockdown
perturbs development of the nervous system, but not the dorsal
mesoderm, where Smurf1 might share redundant functions with
Smurf2, which has a similar expression pattern and target
proteins (Zhang et al., 2001; and our unpublished data).
Alternatively, we may be unable at present to effectively
block Smurf1 in the dorsal mesoderm (see below). In regard to
the neural development, we found that two different aspects
require endogenous Smurf1, namely neural patterning and
neural folding. Notably, maternal-zygotic Drosophila dSmurf
mutants also display both patterning and morphogenetic
defects, the latter revealed by the failure of the hindgut to
narrow, elongate and undergo closure (Podos et al., 2001).
Thus, the ability of Smurfs to regulate both cell fate and cell
movement seems to be evolutionarily conserved.
Smurf1 function in mesoderm induction and patterning
Smurf1 knockdown reagents targeted to the mesoderm of
intact embryos did not cause obvious defects, but partially
blocking BMP signaling in the embryo sensitizes the mesoderm
to Smurf1 knockdown: blocking Smurf1 reverses dorsalization
and secondary axis induction by Chordin in whole embryos
(Figs. 10D, E), and Smurf1 inhibition in animal caps ventralizes
their response to dorsal mesoderm-inducing doses of activin
(Supplementary Fig. 3). A similar phenomenon was observed in
a Chordin knockdown study (Oelgeschlager et al., 2003), where
Chordin inhibition by an MO only moderately ventralized
whole embryos, whereas it completely blocked mesoderm
induction in activin-treated animal caps or secondary axis
formation in host embryos implanted with Chordin MO-treated
Spemann Organizers. Smurf1 knockdown by itself in isolated
animal caps, or the DMZ or VMZ of whole embryos, did not
affect development. This might be because even with Smurf1
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sufficiently to alter their normal fates. However, when animal
caps or VMZ tissues are challenged with activin or BMP
inhibitors, respectively, elevated BMP signaling levels caused
by partial Smurf1 knockdown is sufficient to affect fate. The
question of whether Smurf1 plays a role in dorsal marginal zone
development remains unresolved by our present study.
Currently available knockdown techniques may be unable to
completely block Smurf1 function in Xenopus dorsal meso-
derm, possibly because of maternal Smurf1 protein, or because
knockdown of Smurf1 in the DMZ/Spemann Organizer is
insufficient to boost the absent or low levels of BMP signaling
in that region (due to multiple BMP inhibitors in those tissues).
Generation and characterization of hypomorphic, rather than
null Smurf1;Smurf2 double KO mouse embryos (Yamashita et
al., 2005), should help resolve this issue, assuming that Smurf1
function in amphibians and mammals is conserved.
The molecular target of embryonic Smurf1
Smurf1 binds a variety of well-characterized and also novel
proteins (Barrios-Rodiles et al., 2005; our unpublished Yeast
Two Hybrid data). Stabilization of one or more of these
potential substrates could be responsible for Smurf1 KD
phenotype. Analysis of how WW domain deletion mutants of
Smurf1CA affect Xenopus development (Supplementary Fig. 4)
suggests a mechanism of Smurf1CA dominant-negative
activity, and helps limit the identity of Smurf1 targets relevant
to the present study. Smurf WW domains are known to interact
with one or more PY motifs in partner proteins and substrates
(Pickart, 2001a). We found that deleting either of the two WW
domains in Smurf1CA abolishes its dominant-negative activity,
suggesting that Smurf1CA functions by binding a PY-contain-
ing substrate(s), thereby protecting it from degradation by
endogenous Smurf1. Among proposed Smurf1 substrates,
Smad1/5/8, Smad6, Smad7 and MEKK2 possess a PY motif,
but Alk6, RhoA or Par6 (that bridges RhoA to Smurf1) does
not. Thus, RhoA, an otherwise logical candidate for cell
movement effects (Copp et al., 2003), is unlikely to be involved
in Smurf1 KD phenotypes. This is supported experimentally by
our observation that RhoA overexpression does not mimic
Smurf1 knockdown (Supplementary Fig. 3).
We have built a case that the BMP pathway, at the level of
Smads, is the major physiological target of Smurf1 during early
Xenopus development, but we cannot formally exclude the
possibility that another Smurf1 substrate(s) contributes to the
observed phenotypes. However, even if such substrates exist,
they do not need to be invoked to explain the effects of Smurf1
knockdown. Altered BMP signaling and specifically elevated P-
Smad1 activity are sufficient to explain the effects we observe
when endogenous Smurf1 is blocked. Since Smads are targeted
by Smurf1 via their WW domains, and neither Smad5 nor
Smad8 has not been identified in X. laevis, we suggest that
Smad1 is the principal endogenous target of Smurf1 in early
development of the X. laevis embryo.
Our data show that Smurf1 is required in dorsal ectoderm to
restrict BMP/Smad1 signaling to a level that permits neuraldevelopment. A similar restrictive function has recently been
proposed for Ectodermin, a Smad4-specific ubiquitin ligase that
limits TGF-β signaling in the ectoderm (Dupont et al., 2005).
We suggest that ubiquitin-mediated destruction of intracellular
components of the BMP pathway by ubiquitin ligases, such as
Smurf1, provides another level of BMP antagonism in addition
to extracellular BMP inhibitors secreted from the Spemann
organizer. The fact that Smurf1 is expressed in a gradient across
the animal pole and marginal zone of the gastrula, with highest
levels on the prospective dorsal/anterior side, reinforces this
model.
The timing of Smurf1 function
In Smurf1 KD embryos, regional neural markers are
affected more than general neural markers (Figs. 5, 6). This
suggests that Smurf1 antagonism of BMP/Smad1 signaling
becomes essential after general neural induction has taken
place, and a variety of evidence supports this possibility.
BMP4 and BMP7 are expressed abundantly in proximity to
the neural tube in the epidermis and prechordal plate, and in
the dorsal neural tube itself (Liem et al., 1995; Hartley et al.,
2001). Active P-Smad1/5/8 protein is also directly detectable
at the periphery of the anterior neural plate (Wawersik et al.,
2005). Furthermore, neural patterning is disrupted in trans-
genic Xenopus embryos expressing BMP4 under Pax6
promoter (i.e. in the neural plate; Hartley et al., 2001).
These data indicate that successful neural development
requires BMP/Smad1 pathway suppression continuously
after gastrulation. Thus, as development progresses and the
neural tube extends and expands anteriorly, BMP inhibition
by Organizer- and mesoderm-derived antagonists may become
less effective, while local and cell-autonomous mechanisms,
such as Smad1 ubiquitylation and dephosphorylation (Knock-
aert et al., 2006), take over.
Regulation of cell movements by Smurf1 and Smad1
Besides fate and pattern, Smurf1 knockdown affects the
organization and behavior of neural plate cells, manifested by
defective closure of the anterior neural tube and disruption of f-
actin networks at neural fold hinge points (Fig. 3). Previous
studies implicate BMP/Smad1 signaling in regulation of cell
movements, independent of cell fate, with examples including
zebrafish gastrulation (Myers et al., 2002), pre-migratory neural
crest cell delamination from the dorsal neural tube (Sela-
Donenfeld and Kalcheim, 1999) and ganglion formation by
enteric neural crest cells (Goldstein et al., 2005). The molecular
mechanism of how the BMP/Smad1 pathway regulates cell
movement, however, remains unknown.
Regulation of cell movement independent of cell fate is
commonly accomplished by two non-canonical Wnt pathways,
the Wnt/Ca2+ pathway and the Wnt/planar cell polarity (PCP)
pathway, whose effectors include Ca2+-binding proteins, actin
cytoskeleton regulators, e.g. Rho and Rac, and the Shh pathway
(Kuhl et al., 2000; Copp et al., 2003; Ueno and Greene, 2003;
Zohn et al., 2003; Klein and Mlodzik, 2005; Park et al., 2006).
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been specifically implicated in cranial neural tube closure, such
as Shroom, vinculin, profilin, Mena, MARCKS and RhoGAP
(reviewed in Copp et al., 2003), and knockdown of Shroom in
Xenopus embryos produces a phenotype almost identical to
Smurf1 knockdown (Haigo et al., 2003). One way BMP/Smad1
signaling might regulate cell movements is transcriptional
regulation of a gene(s) involved in actin cytoskeletal dynamics.
In zebrafish embryos, high levels of BMP signaling suppress
transcription of the non-canonical Wnt ligands Wnt5a and
Wnt11 (Myers et al., 2002). However,Wnt5a and Wnt11 are not
expressed in Xenopus prospective neural ectoderm nor
suppressed in Smurf1 KD embryos as a whole (data not
shown), so this mechanism is unlikely to account for the Smurf1
KD phenotype. Moreover, in Smurf1 KD embryos, we
measured the expression levels of a number of other actin
regulators and components of the non-canonical Wnt pathways
(Glypican4, Xfz3, Xfz8, Dishevelled, Strabismus, Shroom,
MARCKS and Prickle) by quantitative RT-PCR, but did not
observe significant deviation in their levels compared to wt
embryos (data not shown). Sonic Hedgehog (Shh) signaling
also regulates neural plate patterning and folding, so we
analyzed expression of Shh and one of its target genes, Nkx2.2,
by in situ hybridization. We found Shh expression mostly
unchanged (data not shown), and Nkx2.2 was down-regulated
in Smurf1 KD embryos that displayed abnormal neural folding
(Figs. 5S–U). However, lack of a tight correlation between
Nkx2.2 suppression and folding defects indicates that abnormal
Shh signaling is probably not responsible for the described
neural tube closure defects. If there is a BMP/Smad1
transcriptional target involved in Xenopus neurulation, it
remains to be identified.
Alternatively, Smad1 may be involved at a post-transcrip-
tional level in cytoskeletal regulation. Several cytoplasmic
Smad1-interacting factors have recently been identified that
potentially regulate actin cytoskeleton and/or cell movements.
These include Dishevelled1 (a Wnt signal transducer), filamin
(an f-actin binding protein), Par3 (a cell/embryo polarity
regulator) and Erbin (which links the tyrosine kinase receptor
ErbB2 to the cytoskeleton and desmosomes) (Sasaki et al.,
2001; Moustakas et al., 2001; Warner et al., 2003; Zwijsen et al.,
2003). Additionally, several members and regulators of the Rho
family interact with Smad1, Smad4 and Alk6 in a co-
immunoprecipitation screen (Barrios-Rodiles et al., 2005). It
would be an intriguing and novel finding if Smad1 operates as
both a transcription factor and a cytoplasmic actin regulator,
analogous to the dual functions of β-catenin.
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